Taurohyodeoxycholic acid alleviates trinitrobenzene sulfonic acid induced ulcerative colitis via regulating Th1/Th2 and Th17/Treg cells balance.

[1]  H. Nakase,et al.  The influence of cytokines on the complex pathology of ulcerative colitis. , 2021, Autoimmunity reviews.

[2]  A. Avan,et al.  Therapeutic effects of silver nanoparticle containing sulfasalazine on DSS-induced colitis model , 2021, Journal of Drug Delivery Science and Technology.

[3]  A. Kijlstra,et al.  Small molecules targeting RORγt inhibit autoimmune disease by suppressing Th17 cell differentiation , 2020, Cell Death & Disease.

[4]  H. Tomita,et al.  Kynurenine plays an immunosuppressive role in 2,4,6-trinitrobenzene sulfate-induced colitis in mice , 2020, World journal of gastroenterology.

[5]  Dong-sheng Wang,et al.  Aggravated ulcerative colitis caused by intestinal Metrnl deficiency is associated with reduced autophagy in epithelial cells , 2020, Acta Pharmacologica Sinica.

[6]  J. Samsom,et al.  Dissecting the Heterogeneity in T-Cell Mediated Inflammation in IBD , 2020, Cells.

[7]  M. Nagarkatti,et al.  Resveratrol Downregulates miR-31 to Promote T Regulatory Cells During Prevention of TNBS-Induced Colitis. , 2019, Molecular nutrition & food research.

[8]  X. Hou,et al.  Estrogen receptor β activation ameliorates DSS-induced chronic colitis by inhibiting inflammation and promoting Treg differentiation. , 2019, International immunopharmacology.

[9]  Mohammad Al Mijan,et al.  Diets, functional foods, and nutraceuticals as alternative therapies for inflammatory bowel disease: Present status and future trends , 2018, World journal of gastroenterology.

[10]  C. Lloyd,et al.  Type 2 immunity: Expanding our view , 2018, Science Immunology.

[11]  D. Hafler,et al.  Regulatory T cells in autoimmune disease , 2018, Nature Immunology.

[12]  E. Imamura,et al.  Anti‐IL‐23 receptor monoclonal antibody prevents CD4+ T cell‐mediated colitis in association with decreased systemic Th1 and Th17 responses , 2018, European journal of pharmacology.

[13]  Nima Hamidi,et al.  Worldwide incidence and prevalence of inflammatory bowel disease in the 21st century: a systematic review of population-based studies , 2017, The Lancet.

[14]  Li Tang,et al.  Iguratimod ameliorates inflammatory responses by modulating the Th17/Treg paradigm in dextran sulphate sodium‐induced murine colitis , 2018, Molecular immunology.

[15]  Michael J. T. Stubbington,et al.  Circulating and Tissue-Resident CD4+ T Cells With Reactivity to Intestinal Microbiota Are Abundant in Healthy Individuals and Function Is Altered During Inflammation , 2017, Gastroenterology.

[16]  Lu Zhang,et al.  Protective effects of paeoniflorin on TNBS‐induced ulcerative colitis through inhibiting NF‐kappaB pathway and apoptosis in mice , 2017, International immunopharmacology.

[17]  P. Henderson,et al.  Inflammatory Bowel Disease Drugs: A Focus on Autophagy , 2016, Journal of Crohn's & colitis.

[18]  Yuan Suo,et al.  Intestinal anti-inflammatory effect of the rhizome extracts of Menispermum dauricum DC. on trinitrobenzene sulfonic acid induced ulcerative colitis in mice. , 2016, Journal of ethnopharmacology.

[19]  Yongming Zhang,et al.  Anti-inflammatory effect of taurocholate on TNBS-induced ulcerative colitis in mice. , 2016, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[20]  L. Peyrin-Biroulet,et al.  Current evidence supporting mucosal healing and deep remission as important treatment goals for inflammatory bowel disease , 2016, Expert review of gastroenterology & hepatology.

[21]  G. Kaplan,et al.  The global burden of IBD: from 2015 to 2025 , 2015, Nature Reviews Gastroenterology &Hepatology.

[22]  W. Strober,et al.  Experimental Models of Inflammatory Bowel Diseases , 2015, Cellular and molecular gastroenterology and hepatology.

[23]  Xiuqin Cheng,et al.  Elevated levels of Th17 cells and Th17-related cytokines are associated with disease activity in patients with inflammatory bowel disease , 2014, Inflammation Research.

[24]  P. Miossec,et al.  Th17 and regulatory T cell balance in autoimmune and inflammatory diseases. , 2014, Autoimmunity reviews.

[25]  R. Glauben,et al.  Histone Deacetylase Inhibitors Modulate Interleukin 6-dependent CD4+ T Cell Polarization in Vitro and in Vivo * , 2014, The Journal of Biological Chemistry.

[26]  Yuan Zhang,et al.  Th1/Th2 cell's function in immune system. , 2014, Advances in experimental medicine and biology.

[27]  F. Powrie,et al.  CD4+ T-cell subsets in intestinal inflammation , 2013, Immunological reviews.

[28]  Fermín Sánchez de Medina,et al.  Dose-dependent antiinflammatory effect of ursodeoxycholic acid in experimental colitis. , 2013, International immunopharmacology.

[29]  Xinying Li,et al.  Dysregulated Tim-3 expression and its correlation with imbalanced CD4 helper T cell function in ulcerative colitis. , 2012, Clinical immunology.

[30]  I. Monteleone,et al.  Th17-related cytokines in inflammatory bowel diseases: friends or foes? , 2012, Current molecular medicine.

[31]  Yongming Zhang,et al.  Protective effect of taurohyodeoxycholic acid from Pulvis Fellis Suis on trinitrobenzene sulfonic acid induced ulcerative colitis in mice. , 2011, European journal of pharmacology.

[32]  Philippe Seksik,et al.  Epidemiology and natural history of inflammatory bowel diseases. , 2011, Gastroenterology.

[33]  Yongming Zhang,et al.  Semi-Preparative Isolation and Purification of Three Tauro-Conjugated Cholic Acids from Pulvis Fellis Suis by HSCCC Coupled with ELSD Detection , 2011, Chromatographia.

[34]  S. Sarna,et al.  Differential immune and genetic responses in rat models of Crohn's colitis and ulcerative colitis. , 2011, American journal of physiology. Gastrointestinal and liver physiology.

[35]  V. Kuchroo,et al.  Interleukin-17 and type 17 helper T cells. , 2009, The New England journal of medicine.

[36]  C. Egwuagu.  STAT3 in CD4+ T helper cell differentiation and inflammatory diseases. , 2009, Cytokine.

[37]  T. Hibi,et al.  Persistent retention of colitogenic CD4+ memory T cells causes inflammatory bowel diseases to become intractable , 2009, Inflammatory bowel diseases.

[38]  A. Timmer,et al.  Azathioprine and 6-mercaptopurine for maintenance of remission in ulcerative colitis. , 2007, The Cochrane database of systematic reviews.

[39]  Y. Wan,et al.  The roles for cytokines in the generation and maintenance of regulatory T cells , 2006, Immunological reviews.

[40]  A. Franchitto,et al.  Effect of taurohyodeoxycholic acid, a hydrophilic bile salt, on bile salt and biliary lipid secretion in the rat , 1994, Digestive Diseases and Sciences.

[41]  S. Targan,et al.  Role of cytokines in the pathogenesis of inflammatory bowel disease. , 2000, Annual review of medicine.

[42]  Garside.  Cytokines in experimental colitis , 1999, Clinical and experimental immunology.

[43]  Hervé Groux,et al.  A CD4+T-cell subset inhibits antigen-specific T-cell responses and prevents colitis , 1997, Nature.

[44]  D. Piani,et al.  Effect of taurohyodeoxycholic acid on biliary lipid secretion in humans , 1993, Hepatology.

[45]  L. Baiocchi,et al.  Dissolution of human cholesterol gallstones in bile salt/lecithin mixtures: effect of bile salt hydrophobicity and various pHs. , 1995, Scandinavian journal of gastroenterology.

[46]  A. Rigotti,et al.  Protective role of biliary cholesterol and phospholipid lamellae against bile acid-induced cell damage. , 1994, Gastroenterology.

[47]  T. Mosmann,et al.  IL-10 acts on the antigen-presenting cell to inhibit cytokine production by Th1 cells. , 1991, Journal of immunology.